Thiamine Tablets
Substance / Alcohol Dependence
NICE recommend single therapy with Thiamine as first line.
Vitamin B Co / Strong should not be used in conjunction with Thiamine.
| Pack | Price |
|---|---|
| 100 tablet | £3.50 |
| Pack | Price |
|---|---|
| 100 tablet | £3.00 |
Alcohol withdrawal
*Hospital use only*
DO NOT PRESCRIBE IN PRIMARY CARE
Due to the genotoxic potential of Chlordiazepoxide , women of childbearing potential should use effective contraceptive measures while being treated with Librium and for 7 months following completion of treatment.
If the patient suspects to be pregnant or intends to become pregnant, she should be warned to contact her physician to discuss discontinuation of Librium.
Men are recommended to use effective contraceptive measures and to not father a child while receiving Librium and for 4 months following completion of treatment. (May 2022)
Substance Dependence, Dietary Supplements
*Hospital Use Only*
Review Date: 01/12/2021
Substance Dependence, Nutritional Supplements
*Hospital Use Only*
Review Date: 01/03/2028
Acamprosate Pre-exisiting Patients - Do not initiate new patients
Alcohol disorders - maintenance of abstinence
Brand: Campral EC
NICE CG 115 Alcohol Use Disorders
Acamprosate may be continued to be prescribed in Primary Care for pre-existing/historical patients, however no new patients should be initiated by, or transferred into, Primary Care. Acamprosate must be offered in combination with an individual psychological intervention (cognitive behavioural therapies, behavioural therapies or social network and environment-based therapies) focused specifically on alcohol misuse
| Pack | Price |
|---|---|
| 168 tablet | £21.29 |
Review Date: 01/03/2028
Disulfiram Pre-existing patients
Alcohol disorders - maintenance of abstinence
Brand: Antabuse
Rationale 1,2
NICE CG 115 Alcohol Use Disorders
Disulfiram may be continued to be prescribed in Primary Care for pre-existing/historical patients, however no new patients should be initiated by, or transferred to, Primary Care.
Disulfiram can be offered in combination with an individual
psychological intervention (cognitive behavioural therapies, behavioural therapies or social network and environment-based therapies) focused specifically on alcohol misuse
Review Date: 01/03/2028
Alcohol disorders - maintenance of abstinence
Brand: Campral EC
Do Not initiate new patients
Rationale: 1,2
NICE CG 115 Alcohol Use Disorders
Acamprosate may be continued to be prescribed in Primary Care for pre-existing/historical patients, however no new patients should be initiated by, or transferred into, Primary Care. Acamprosate must be offered in combination with an individual psychological intervention (cognitive behavioural therapies, behavioural therapies or social network and environment-based therapies) focused specifically on alcohol misuse
Review Date: 01/03/2028
Alcohol disorders - maintenance of abstinence
Brand: Antabuse
Rationale 1,2
Do Not initiate new patients
NICE CG 115 Alcohol Use Disorders
Disulfiram may be continued to be prescribed in Primary Care for pre-existing/historical patients, however no new patients should be initiated by, or transferred to, Primary Care.
Disulfiram can be offered in combination with an individual
psychological intervention (cognitive behavioural therapies, behavioural therapies or social network and environment-based therapies) focused specifically on alcohol misuse
Review Date: 01/10/2026
Alcohol disorders
Brand : Selincro
Rationale 1,2,8
Nalmefene is recommended within its marketing authorisation, as an option for reducing alcohol consumption, for people with alcohol dependence:
* who have a high drinking risk level (defined as alcohol consumption of more than 60 g per day for men and more than 40 g per day for women, according to the World Health Organization's drinking risk levels) without physical withdrawal symptoms and
* who do not require immediate detoxification.
The marketing authorisation states that nalmefene should:
* only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption and
* be initiated only in patients who continue to have a high drinking risk level 2 weeks after initial assessment.
November 2014
Review Date: 01/02/2028
NICE CG115 - Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence
| Pack | Price |
|---|---|
| 28 tablet | £0.91 |